Cargando…
Gut Microbiota-Derived Short-Chain Fatty Acids: Impact on Cancer Treatment Response and Toxicities
The gut microbiota has emerged as a key modulator of cancer treatment responses in terms of both efficacy and toxicity. This effect is clearly mediated by processes impacting the activation and modulation of immune responses. More recently, the ability to regulate chemotherapeutic drug metabolism ha...
Autores principales: | Al-Qadami, Ghanyah H., Secombe, Kate R., Subramaniam, Courtney B., Wardill, Hannah R., Bowen, Joanne M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612155/ https://www.ncbi.nlm.nih.gov/pubmed/36296324 http://dx.doi.org/10.3390/microorganisms10102048 |
Ejemplares similares
-
Oral-Gut Microbiome Axis in the Pathogenesis of Cancer Treatment-Induced Oral Mucositis
por: Al-Qadami, Ghanyah, et al.
Publicado: (2022) -
Guidelines for reporting on animal fecal transplantation (GRAFT) studies: recommendations from a systematic review of murine transplantation protocols
por: Secombe, Kate R., et al.
Publicado: (2021) -
From Pathogenesis to Intervention: The Importance of the Microbiome in Oral Mucositis
por: Bruno, Julia S., et al.
Publicado: (2023) -
Gut Microbiota-Derived Short-Chain Fatty Acids, T Cells, and Inflammation
por: Kim, Chang H., et al.
Publicado: (2014) -
Gut microbiota–derived short-chain fatty acids and kidney diseases
por: Li, Lingzhi, et al.
Publicado: (2017)